Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 1
1995 3
1997 6
1998 3
1999 4
2000 5
2001 3
2002 12
2003 13
2004 5
2005 16
2006 14
2007 24
2008 18
2009 23
2010 23
2011 28
2012 26
2013 34
2014 47
2015 58
2016 40
2017 49
2018 55
2019 68
2020 83
2021 113
2022 84
2023 92
2024 43

Text availability

Article attribute

Article type

Publication date

Search Results

866 results

Results by year

Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
Comprehensive Review on Alzheimer's Disease: Causes and Treatment.
Breijyeh Z, Karaman R. Breijyeh Z, et al. Molecules. 2020 Dec 8;25(24):5789. doi: 10.3390/molecules25245789. Molecules. 2020. PMID: 33302541 Free PMC article. Review.
This review discusses currently available drugs and future theories for the development of new therapies for AD, such as disease-modifying therapeutics (DMT), chaperones, and natural compounds....
This review discusses currently available drugs and future theories for the development of new therapies for AD, such as disease-modi …
New Avenues for the Treatment of Huntington's Disease.
Kim A, Lalonde K, Truesdell A, Gomes Welter P, Brocardo PS, Rosenstock TR, Gil-Mohapel J. Kim A, et al. Int J Mol Sci. 2021 Aug 4;22(16):8363. doi: 10.3390/ijms22168363. Int J Mol Sci. 2021. PMID: 34445070 Free PMC article. Review.
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG expansion in the HD gene. The disease is characterized by neurodegeneration, particularly in the striatum and cortex. The first symptoms usually appear in mid-life and include cognitive deficits and …
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG expansion in the HD gene. The disease is characterized by neuro …
Obesity and male infertility: Mechanisms and management.
Leisegang K, Sengupta P, Agarwal A, Henkel R. Leisegang K, et al. Andrologia. 2021 Feb;53(1):e13617. doi: 10.1111/and.13617. Epub 2020 May 12. Andrologia. 2021. PMID: 32399992 Review.
Complications of obesity include cardiovascular diseases, type 2 diabetes mellitus, malignancy (including prostatic cancer), neurodegeneration and accelerated ageing. In males, these further include erectile dysfunction, poor semen quality and subclinical prostatitis. ...
Complications of obesity include cardiovascular diseases, type 2 diabetes mellitus, malignancy (including prostatic cancer), neurodegener …
Wolfram Syndrome: Diagnosis, Management, and Treatment.
Urano F. Urano F. Curr Diab Rep. 2016 Jan;16(1):6. doi: 10.1007/s11892-015-0702-6. Curr Diab Rep. 2016. PMID: 26742931 Free PMC article. Review.
Wolfram syndrome is a rare genetic disorder characterized by juvenile-onset diabetes mellitus, diabetes insipidus, optic nerve atrophy, hearing loss, and neurodegeneration. Although there are currently no effective treatments that can delay or reverse the progression of Wo …
Wolfram syndrome is a rare genetic disorder characterized by juvenile-onset diabetes mellitus, diabetes insipidus, optic nerve atrophy, hear …
Parkinson's disease: Mechanisms, translational models and management strategies.
Raza C, Anjum R, Shakeel NUA. Raza C, et al. Life Sci. 2019 Jun 1;226:77-90. doi: 10.1016/j.lfs.2019.03.057. Epub 2019 Apr 10. Life Sci. 2019. PMID: 30980848 Review.
Preclinical research may provide powerful tools to quest the potential therapeutic and neuroprotective compounds for dopaminergic neurons and hence possible cure for the Parkinson's disease....
Preclinical research may provide powerful tools to quest the potential therapeutic and neuroprotective compounds for dopaminergic neu …
Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention.
Mahaman YAR, Embaye KS, Huang F, Li L, Zhu F, Wang JZ, Liu R, Feng J, Wang X. Mahaman YAR, et al. Ageing Res Rev. 2022 Feb;74:101544. doi: 10.1016/j.arr.2021.101544. Epub 2021 Dec 18. Ageing Res Rev. 2022. PMID: 34933129 Review.
Its main histological hallmarks are the Abeta senile plaques and the P-tau neurofibrillary tangles, while clinically it is marked by a progressive cognitive decline that reflects the underlying synaptic loss and neurodegeneration. Many of the drug therapies targetin …
Its main histological hallmarks are the Abeta senile plaques and the P-tau neurofibrillary tangles, while clinically it is marked by a progr …
Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells.
Stoddard-Bennett T, Reijo Pera R. Stoddard-Bennett T, et al. Cells. 2019 Jan 7;8(1):26. doi: 10.3390/cells8010026. Cells. 2019. PMID: 30621042 Free PMC article. Review.
Many current therapies of PD can only address the symptoms and not the underlying neurodegeneration of PD. ...Recent advances in the field of cellular reprogramming and personalized medicine now allow for previously unattainable cell therapies and patient-spe …
Many current therapies of PD can only address the symptoms and not the underlying neurodegeneration of PD. ...Recent advances …
Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts.
McKee AC, Stein TD, Huber BR, Crary JF, Bieniek K, Dickson D, Alvarez VE, Cherry JD, Farrell K, Butler M, Uretsky M, Abdolmohammadi B, Alosco ML, Tripodis Y, Mez J, Daneshvar DH. McKee AC, et al. Acta Neuropathol. 2023 Apr;145(4):371-394. doi: 10.1007/s00401-023-02540-w. Epub 2023 Feb 10. Acta Neuropathol. 2023. PMID: 36759368 Free PMC article. Review.
Cognitive symptoms of Alzheimer's disease: clinical management and prevention.
Joe E, Ringman JM. Joe E, et al. BMJ. 2019 Dec 6;367:l6217. doi: 10.1136/bmj.l6217. BMJ. 2019. PMID: 31810978 Review.
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by the accumulation of amyloid beta in the form of extracellular plaques and by intracellular neurofibrillary tangles, with eventual neurodegeneration and dementia. There is currently no dise …
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by the accumulation of amyloid beta in the form of extrace …
866 results